Skip to main content

Nonmelanoma Skin Cancer Actinic Keratosis and Squamous Cell Carcinoma

  • Chapter
  • First Online:
Mechanisms of Molecular Carcinogenesis – Volume 2

Abstract

Nonmelanoma skin cancer is the most common malignant tumor in Caucasians. Its pathogenesis is multifactorial. With a special focus on actinic keratosis and squamous cell carcinoma, we will give a short overview concerning basic knowledge and current histological classifications. Further, we discuss tumorigenesis and influencing factors, such as UV radiation, the inflammatory environment, hypoxia, presence of viruses, and the roles of the innate and adaptive immune system. Moreover, we give a short overview about targeted therapy of actinic keratosis and squamous cell carcinoma.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 129.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 169.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Diepgen TL, Mahler V. The epidemiology of skin cancer. Br J Dermatol. 2002;146(61):1–6.

    Article  PubMed  Google Scholar 

  2. Hoey SE, Devereux CE, Murray L, Catney D, Gavin A, Kumar S, Donnelly D, Dolan OM. Skin cancer trends in Northern Ireland and consequences for provision of dermatology services. Br J Dermatol. 2007;156:1301–7.

    Article  CAS  PubMed  Google Scholar 

  3. Madan V, Lear JT, Szeimies RM. Non melanoma skin cancer. Lancet. 2010;375:673–85.

    Article  CAS  PubMed  Google Scholar 

  4. Martinez JC, Otley CC. The management of melanoma and non-melanoma skin cancer: a review for the primary care physician. Mayo Clin Proc. 2001;76:1253–65.

    Article  CAS  PubMed  Google Scholar 

  5. Ratushny V, Gober MD, Hick R, Ridky TW, Sexkora JT. From keratinocyte to cancer: the pathogenesis and melding of cutaneous squamous cell cancer. J Clin Invest. 2012;122(2):464–72.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  6. Salasche SJ. Epidemiology of actinic keratosis and squamous cell carcinoma. J Am Acad Dermatol. 2000;42:4–7.

    Article  CAS  PubMed  Google Scholar 

  7. Lambert SR, Mladkova N, Gulati A, Hamoudi R, Purdie K, Cerio R, Leigh I, Proby C, Harwood CA. Key differences identified between actinic keratosis and cutaneous squamous cell carcinoma by transcriptome profiling. Br J Cancer. 2014;110:520–9.

    Article  CAS  PubMed  Google Scholar 

  8. Pfister DG, Harpern AC. Skin squamous cell cancer: the tie is right for greater involvement of the medical oncologist. J Clin Oncol. 2007;25(15):1953–4.

    Article  PubMed  Google Scholar 

  9. Rosso S, Zanetti R, Martinez C, Tormi MJ, Schraub S, Sancho-Garnier H, Franceschi S, Gafa L, Perea E, Navarro C, Laurent R, Schrameck C, Talamini R, Tumino R, Wechseler J. The multicenter south European study “Helios”. II: Different sun exposure patterns in the aetiology of basal cell and squamous cell carcinomas of the skin. Br J Cancer. 1996;73(11):1447–54.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  10. Yoong C, De’Ambrosis B. Cutaneous invasive squamous cell carcinoma: 10-year experience and recommendations for follow up. Australas J Dermatol. 2009;50:261–5.

    Article  PubMed  Google Scholar 

  11. Ackerman AB. Solar keratosis is squamous cell carcinoma. Arch Dermatol. 2003;139:1216–7.

    Article  PubMed  Google Scholar 

  12. Memon AA, Tomenson JA, Bothwell J, Friedmann PS. Prevalence of solar damage and actinic keratosis in a Merseyside population. Br J Dermatol. 2000;142:1154–9.

    Article  CAS  PubMed  Google Scholar 

  13. Glogau RG. The risk of progression to invasive disease. J Am Acad Dermatol. 2000;42:23–4.

    Article  CAS  PubMed  Google Scholar 

  14. Jensen V, Prasad AR, Smith A, Raju M, Wendel CS, Schmelz M, Leyva W, Warneke J, Krouse RS. Prognostic criteria for squamous cell cancer of the skin. J Surg Res. 2010;159:509–16.

    Article  CAS  PubMed  Google Scholar 

  15. Harwood CA, Leedham-Green M, Leigh IM, Proby CM. Low-dose retinoids in the prevention of cutaneous squamous cell carcinomas in organ transplant recipients: a 16-year retrospective study. Arch Dermatol. 2005;141:456–64.

    Article  CAS  PubMed  Google Scholar 

  16. Röwert-Huber J, Patel MJ, Forschner T, Ulrich C, Eberle J, Kerl H, Sterry W, Stockfleth E. Actinic keratosis is an early in situ squamous cell carcinoma: a proposal for reclassification. Br J Dermatol. 2007;156(Suppl 3):8–12.

    Article  PubMed  Google Scholar 

  17. Breuninger H, Eigentler T, Bootz F, Hauschild A, Kortmann RD, Wolff K, Stockfleth E, Szeimies RM, Rompel R, Garbe C, Grabbe S. Brief S2k guidelines- cutaneous squamous cell carcinoma. J Dtsch Dermatol Ges. 2013;11(3):37–45.

    Article  PubMed  Google Scholar 

  18. Berman B, Cockerell CJ. Pathobiology of actinic keratosis: ultraviolet-dependent keratinocyte proliferation. J Am Acad Dermatol. 2013;68(1):10–9.

    Article  Google Scholar 

  19. Brash DE, Ziegler A, Jonason AS, Simon JA, Kunala S, Leffel DJ. Sunlight and sunburn in human skin cancer: p53, apoptosis, and tumor promotion. J Investig Dermatol Symp Proc. 1996;1:136–42.

    CAS  PubMed  Google Scholar 

  20. Meyer N, Peyret-Lacombe A, Canguilhelm B, Medale-Giamarchi C, Mamouni K, Cristini A, Monferran S, Lamant L, Filleron T, Pradines A, Sordet O, Favre G. RhoB promotes cancer initiation by protecting keratinocytes from UVB- induced apoptosis but limits tumor aggressiveness. J Invest Dermatol. 2014;134:203–12.

    Article  CAS  PubMed  Google Scholar 

  21. Buckman SY, Gresham A, Hale P, Hruza G, Anast J, Masferrer J, Pentland AP. Cox2 expression s induced by UVB exposure in human skin: implications for the development of skin cancer. Carcinogenesis. 1998;19:723–9.

    Article  CAS  PubMed  Google Scholar 

  22. Andreu P, Johansson M, Affara NI, Pucci F, Tan T, Junankar S, Korets L, Lam J, Tawfik D, DeNardo DG, Naldini L, de Visser KE, De Palma M, Coussens LM. FcRγ activation regulates inflammation-associated squamous carcinogenesis. Cancer Cell. 2010;17:121–34.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  23. Balkwill F, Charles KA, Mantovani A. Smoldering and polarized inflammation in the initiation and promotion of malignant disease. Cancer Cell. 2005;7:211–7.

    Article  CAS  PubMed  Google Scholar 

  24. Germano G, Allavena P, Mantovani A. Cytokines as a key component of cancer-related inflammation. Cytokine. 2008;43:374–9.

    Article  CAS  PubMed  Google Scholar 

  25. Grivennikov SI, Greten FR, Karin M. Immunity, inflammation and cancer. Cell. 2010;140:883–99.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  26. Mantovani A, Pierotti MA. Cancer and inflammation: a complex relationship. Cancer Lett. 2008;267:180–1.

    Article  CAS  PubMed  Google Scholar 

  27. Gambichler T, Skrygan M, Hyun J, Bechara F, Tomi NS, Altmeyer P, Kreuter A. Cytokine mRNA expression in basal cell carcinoma. Arch Dermatol Res. 2006;298:139–41.

    Article  CAS  PubMed  Google Scholar 

  28. Szepietowski JC, Walker C, McKenna DB, Hunter JA, McKenzie RC. Leukemia inhibitory factor and interleukin-8 expression in non melanoma skin cancers. Clin Exp Dermatol. 2001;26:72–8.

    Article  CAS  PubMed  Google Scholar 

  29. Yen HAT, Chiang LC, Wen KH, Tsai CC, Yu CL, Yu HS. The expression of cytokines by an established basal cell carcinoma cell line (BCC-1/KMC) compared with cultured normal keratinocytes. Arch Dermatol Res. 1996;288:157–61.

    Article  CAS  PubMed  Google Scholar 

  30. Mantovani A, Allavena P, Sica A, Balkwill F. Cancer-related inflammation. Nature. 2008;454:436–44.

    Article  CAS  PubMed  Google Scholar 

  31. Schioppa T, Moore R, Thompson RG, Rosser EC, Kulbe H, Nedospasov S, Mauri C, Coussens LM, Balkwill FR. B regulatory cells and the tumor-promoting actions of TNF -α during squamous carcinogenesis. Proc Natl Acad Sci U S A. 2011;108(26):10662–1066.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  32. De Visser KE, Coussens LM. The interplay between innate and adaptive immunity regulates cancer development. Cancer Immunol Immunother. 2005;54:1143–52.

    Article  CAS  PubMed  Google Scholar 

  33. Lin WW, Karin M. A cytokine-mediated link between innate immunity, inflammation and cancer. J Clin Invest. 2007;117(5):1175–83.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  34. De Visser KE, Eichten A, Coussens LE. Paradoxical roles of the immune system during cancer development. Nature. 2006;6(1):24–37.

    CAS  Google Scholar 

  35. Coussens LM, Werb Z. Inflammation and cancer. Nature. 2002;420:860–7.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  36. Bose F, Raeli L, Garutti C, Frigerio E, Cozzi A, Crimi M, Caprioli F, Scavelli R, Altomare G, Geginat J, Abrignani S, Reali E. Dual role of anti-TNF therapy: enhancement of TCR-mediated T cell activation in peripheral blood and inhibition of inflammation in target tissues. Clin Immunol. 2011;139:164–76.

    Article  CAS  PubMed  Google Scholar 

  37. Zaidi RM, Merlino G. The two faces of interferon-γ in cancer. Clin Cancer Res. 2011;17(19):6118–24.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  38. Pietrzak AT, Zalewska A, Chodorowska G, Krasowska D, Michalak-Stoma A, Nockowski P, Osemlak P, Paskowski T, Rolinski JM. Cytokines and anticytokines in psoriasis. Clin Chim Acta. 2008;394:7–21.

    Article  CAS  PubMed  Google Scholar 

  39. Berhane T, Halliday GM, Cooke B, Barnetson RS. Inflammation is associated with progression of actinic keratosis to squamous cell carcinomas in humans. Br J Dermatol. 2002;146:810–5.

    Article  CAS  PubMed  Google Scholar 

  40. Hilbert DM, Kopf M, Mock BA, Köhler G, Rudikoff S. Interleukin 6 is essential for in vivo development of B lineage neoplasms. J Exp Med. 1995;182:243–8.

    Article  CAS  PubMed  Google Scholar 

  41. Smith CW, Chen Z, Dong G, Loukinova E, Pegram MY, Nicholas-Figueroa L, Van Waes C. The host environment promotes the development of primary and metastatic squamous cell carcinomas that constitutively express proinflammatory cytokines IL-1alpha, IL-6, GM-CSF, and KC. Clin Exp Metastasis. 1998;16(7):655–64.

    Article  CAS  PubMed  Google Scholar 

  42. Matsuura H, Sakaue M, Subbaramaiahi K, Kamitani H, Eling TE, Dannenbergi AJ, Tanabe T, Inoue H, Arata J, Jetten AM. Regulation of cyclooxygenase-2 by interferon g and transforming growth factor a in normal human epidermal keratinocytes and squamous carcinoma cells. J Biol Chem. 1999;274(41):29138–48.

    Article  CAS  PubMed  Google Scholar 

  43. Brocker EB, Zwaldo G, Holzmann B, Macher E, Sorg C. Inflammatory cell infiltrates in human melanoma at different stages of tumor progression. Int J Cancer. 1988;41(4):526–7.

    Article  Google Scholar 

  44. Asadullah K, Döcke WD, Sabat R, Ebeling M, Volk HD, Sterry W. Interleukin-10 in der Dermatologie. Hautarzt. 1999;50:12–9.

    Article  CAS  PubMed  Google Scholar 

  45. Kim J, Modlin RL, Moy RL, Dubinett SM, McHugh T, Nickoloff BJ, Uyemura K. IL-10 production in cutaneous basal and squamous cell carcinomas. J Immunol. 1995;155:2240–7.

    CAS  PubMed  Google Scholar 

  46. Huang SJ, Hijnen D, Murphy GF, Kupper TS, Calarese AW, Mollet IG, Schanbacher CF, Miller DM, Schmults D, Clark RA. Imiquimod enhances IFN-gamma production and effector function of T cells infiltrating human squamous cell carcinoma of the skin. J Invest Dermatol. 2009;126:2676–85.

    Article  Google Scholar 

  47. De Visser KE, Korets LV, Coussens LM. De novo carcinogenesis promoted by chronic inflammation is B lymphocyte dependent. Cancer Cell. 2005;7:411–23.

    Article  CAS  PubMed  Google Scholar 

  48. Mantovani A, Biswas SK, GAldiero MR, Sica A, Locati M. Macrophage plasticity and polarization in tissue repair and remodelling. J Pathol. 2013;229:176–85.

    Article  CAS  PubMed  Google Scholar 

  49. Sica A, Mantovani A. Macrophage plasticity and polarization: in vivo veritas. J Clin Invest. 2012;122(3):787–95.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  50. Riihila PM, Nissinen LM, Ala-aho R, Kallajoki M, Grenman R, Meri S, Peltonen S, Peltonen J, Kähäri VM. Complement factor H: a biomarker for progression of cutaneous squamous cell cancer. J Invest Dermatol. 2014;134(2):498–506.

    Article  PubMed  Google Scholar 

  51. Eltzschig HK, Carmeliet P. Hypoxia and inflammation. N Engl J Med. 2011;364:656–65.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  52. Arron ST, Jennings L, Nindl I, Rosl F, Bavinck BB, Seckin D, Trakatelli M, Murphy GM. Viral oncogenesis and its role in nonmelanoma skin cancer. Br J Dermatol. 2011;164:1201–13.

    Article  PubMed  Google Scholar 

  53. Akgul B, Bostanci N, Westphal K, Nindl I, Navsaria H, Storey A, Pfister H. Human papillomavirus 5 and 8 E6 downregulate interleukin-8 secretion in primary human keratinocytes. J Gen Virol. 2010;91:888–92.

    Article  PubMed  Google Scholar 

  54. Madkan VK, Cook-Norris RH, Steadman MC, Arora A, Mendoza N, Tyring SK. The oncogenic potential of human papillomaviruses: a review on the role of host genetics and environmental cofactors. Br J Dermatol. 2007;57:228–41.

    Article  Google Scholar 

  55. Kaech SM, Wherry EJ. Heterogeneity and cell-fate decisions in effector and memory CD8+ T cell differentiation during viral infection. Immunity. 2007;27:393–405.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  56. Virgin HW, Wherry EJ, Ahmed R. Redefining chronic viral infection. Cell. 2009;138:30–50.

    Article  CAS  PubMed  Google Scholar 

  57. Wherry JE, Ha SJ, Kaech SM, Haining WN, Sarkar S, Kalia V, Subramaniam S, Blattman JN, Barber DL, Ahmed R. Molecular signature of CD8+ T cell exhaustion during chronic viral infection. Immunity. 2007;27:670–84.

    Article  CAS  PubMed  Google Scholar 

  58. Klenerman P, Hill A. T cells and viral persistence: lessons from diverse infections. Nat Immunol. 2005;6(9):873–9.

    Article  CAS  PubMed  Google Scholar 

  59. Dreno B, Amici JM, Basset-Seguin N, Cribier B, Claudel JP, Richard MA. Management of actinic keratosis: a practical report and treatment algorithm from AKTeam expert clinicians. J Eur Acad Dermatol Venereol. 2014;28:1141–9.

    Article  CAS  PubMed  Google Scholar 

  60. Stockfleth E, Terhorst D, Hausschild A, Zouboulis CC, SChlaeger M, Oster-Schmidt C, Diiepgen T, Gollnick H, Korting HC, Merk H, Sterry W, Kerl K, Berking C. S1 Letilinie zur Behandlung der aktinischen Keratosen. 2011. AWMF Link: http://www.awmf.org/uploads/tx_szleitlinien/013-041l_S1_Aktinische_Keratose_2012-verlaengert.pdf.

  61. Werner RN, Stockfleth E, Connolly SM, Correia O, Erdmann R, Foley P, Gupta AK, Jacobs A, Kerl H, Lim HW, Martin G, Paquet M, Pariser DM, Rosumeck S, Röwert-Huber HJ, Sahota A, Sangueza OP, Shumack S, Sporbeck B, Swanson NA, Torezan L, Nast A. Evidence- and consensus-based (S3) Guidelines for the Treatment of Actinic Keratosis—International League of Dermatological Societies in cooperation with the European Dermatology Forum—Short version. J Eur Acad Dermatol Venereol. 2015;29(11):2069–79. doi:10.1111/jdv.13180.

    Article  CAS  PubMed  Google Scholar 

  62. Bonerandi JJ, Beauvillain CL, Chassagne JF, Chaussade V, Clavere P, Desouches C, Garnier F, Grossin M, Jourdain A, Lemonnier JY, Maillard H, Ortonna N, Rio E, Simon E, Sei JF, Grob JJ, Martin L. Guidelines for the diagnosis and treatment of cutaneous squamous cell carcinoma and precursor lesions. J Eur Acad Dermatol Venereol. 2011;25(5):1–51.

    Article  PubMed  Google Scholar 

  63. Spallone G, Botti E, Costanzo A. Targeted therapy in non melanoma skin cancers. Cancers. 2011;3:2255–73.

    Article  PubMed  PubMed Central  Google Scholar 

  64. Edge SB, Byrd DR, Compton CC, et al. AJCC cancer staging manual. 7th ed. New York: Springer; 2010.

    Google Scholar 

  65. Stratigos A, Garbe C, Lebbe C, Malvehy J, del Marmol V, Pehamberger H, Peris K, Becker JC, Zalaudek I, Saiag P, Middleton MR, Bastholt L, Testori A, Grob JJ. Diagnosis and treatment of invasive squamous cell carcinoma of the skin: European consensus-based interdisciplinary guideline. Eur J Cancer. 2015;51(14):1989–2007.

    Article  PubMed  Google Scholar 

  66. Rudnick EW, Thareja S, Cherpelis B. Oral therapy for nonmelanoma skin cancer in patients with advanced disease and large tumor burden: a review of the literature with focus on a new generation of targeted therapies. Int J Dermatol. 2015;55(3):249–58. doi:10.1111/ijd.12961.

    Article  PubMed  Google Scholar 

  67. Galer CE, Corey CL, Wang Z, Younes MN, Gomez-Rivera F, Sa J, Ludwig DL, El-Naggar AK, Weber RS, Myers JN. Dual inhibition of epidermal growth factor receptor and insulin- like growth factor receptor 1 reduces angiogenesis and tumor growth in cutaneous squamous cell carcinoma. Head Neck. 2011;33:189–98.

    Article  PubMed  PubMed Central  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Birgit Aigner .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2017 Springer International Publishing AG

About this chapter

Cite this chapter

Aigner, B., Legat, F., Weger, W. (2017). Nonmelanoma Skin Cancer Actinic Keratosis and Squamous Cell Carcinoma. In: Haybaeck, J. (eds) Mechanisms of Molecular Carcinogenesis – Volume 2. Springer, Cham. https://doi.org/10.1007/978-3-319-53661-3_2

Download citation

Publish with us

Policies and ethics